ROTTAPHARM BIOTECH

rottapharm-biotech-logo

Rottapharm Biotech is an R&D company dedicated to innovative drug discovery. Born as a research-and-technology-driven company, Rottapharm Biotech is the spin-off of the former R&D division of Rottapharm|Madaus, of which it retained the whole capabilities, infrastructures, and innovative drug discovery programs and assets.

#SimilarOrganizations #Financial #More

ROTTAPHARM BIOTECH

Industry:
Biotechnology

Status:
Active

Contact:
+39.039.9066.104

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Apache Wordpress Plugins Sitelinks Search Box Euro Organization Schema


Similar Organizations

avammune-therapeutics-logo

Avammune Therapeutics

Avammune Therapeutics is a drug discovery company.

neupharma-logo

NeuPharma

NeuPharma is a biotech company dedicated to research and development of innovative medicines.

reaction-biology-logo

Reaction Biology

Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery

Investments List

Date Company Article Money raised
2018-09-24 Altheia Science Rottapharm Biotech investment in Series A - Altheia Science 11 M USD

More informations about "Rottapharm Biotech"

Rottapharm Biotech | Innovating Drug Development for Over 50 …

May 31, 2024 · Discover Rottapharm Biotech, a leader in biotechnology focused on the development of novel drugs and strategic partnerships. Explore our latest advancements in …See details»

About Us - Rottapharm Biotech

For the conduct of its business and in the management of its relationships, Rottapharm Biotech S.r.l. refers to and adheres to the Code of Ethics of Fidim. Rottapharm Biotech S.r.l. è una Società a socio unico del Gruppo Fidim, con …See details»

Rottapharm Biotech - Crunchbase Investor Profile & Investments

Born as a research-and-technology-driven company, Rottapharm Biotech is the spin-off of the former R&D division of Rottapharm|Madaus, of which it retained the whole capabilities, …See details»

Organization | Rottapharm

Center for Research Innovation in Biotechnology (CRIB) College of Pharmacy in collaboration with Clinical Drug Experience KnowledgebaseSee details»

Rottapharm - Crunchbase Company Profile & Funding

Rottapharm’s long history of success began in 1961 with the creation of a small laboratory of independent research. From then on, the company has always invested on research, innovation, development and distribution on a world …See details»

Rottapharm Biotech S.r.l. - Life-Sciences-Europe.com

Nov 1, 2008 · Rottapharm Biotech is an R&D company dedicated to innovative drug discovery and development. Rottapharm Biotech operates with an integrated discovery model that …See details»

Rottapharm Biotech - Investments, Portfolio & Company Exits

Sep 24, 2018 · Rottapharm Biotech is an R&D company dedicated to innovative drug discovery.See details»

Meda to acquire Rottapharm, creating a European ... - Fierce Pharma

Jul 31, 2014 · Meda announced today that it has entered into a definitive agreement to acquire Rottapharm│Madaus ("Rottapharm"), an Italian company owned by the Rovati family, for a …See details»

Rottapharm Biotech Srl - VentureRadar

Rottapharm Biotech is a research company dedicated to the discovery and development of innovative drugs. The company expertise in research and... ... Find out more about …See details»

People - Rottapharm Biotech

Our Management is a true combination of leadership, talent, scientific knowledge, and ability to work as a team. An interdisciplinary group of people with a history of success, enriched over time by newcomers with a proven track record who …See details»

Rottapharm Biotech s.r.l. - BioCentury Company Profiles - BCIQ

Explore BCIQ profiles by entering a company name. Website: http://www.rottapharmbiotech...See details»

Rottapharm Biotech: POC in osteoarthritis pain

Oct 2, 2019 · Results of the proof-of-concept trial suggest the selective imidazoline-2 (I2) receptor agonist CR4056 could be an alternative to the side-effect-prone opioid analgesics in the …See details»

Today - Rottapharm Biotech

Born as a research-and-technology-driven company, Rottapharm Biotech is the spin-off of the former R&D division of Rottapharm|Madaus, of which it retained the whole capabilities, …See details»

Our Approach - Rottapharm Biotech

Rottapharm Biotech is a research company dedicated to the discovery and development of innovative drugs. We operate with a mixed model which includes the development of our own …See details»

CR-10049 - Drug Targets, Indications, Patents - Synapse - Patsnap

CR-10049, Initially developed by Rottapharm Biotech SRL, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Skin and Musculoskeletal Diseases, Active Indication: …See details»

Rottapharm Biotech - Contacts, Employees, Board Members

Rottapharm Biotech is an R&D company dedicated to innovative drug discovery.See details»

CR 4056 - AdisInsight - Springer

Dec 1, 2022 · CR 4056, a first-in-class, oral small molecule, imidazoline I2 ligand, is being developed by Rottapharm Biotech (a spin-off from Rottapharm Madaus) for theSee details»

CR-14629 - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 · Understand key drug designations in just a few clicks with Synapse. CR-14629, Initially developed by Rottapharm Biotech SRL, Now, its global highest R&D status is …See details»

Rottapharm Biotech - Tech Stack, Apps, Patents & Trademarks

Nov 1, 2024 · Rottapharm Biotech is ranked 12,381,952 among websites globally based on its 154 monthly web visitors. Rottapharm Biotech is an R&D company dedicated to innovative …See details»

How Life Sciences Companies Can Use OKRs | Article | Lattice

Nov 4, 2024 · For organizational alignment, biotechnology company Forge Biologics used Lattice to provide broader visibility into the company’s goals. “I really think it's going to help connect …See details»

linkstock.net © 2022. All rights reserved